Pfizer ends rollout of Beqvez, putting another dent in hemophilia gene therapy fieldnews2025-02-21T12:24:53+00:00February 21st, 2025|Endpoints News|
Biotech is still trying to make CRISPR a successnews2025-02-19T15:00:35+00:00February 19th, 2025|Endpoints News|
Thermo Fisher to lay off 300 workers at two viral vector factories news2025-02-03T16:17:10+00:00February 3rd, 2025|Endpoints News|
Cargo Therapeutics cuts lead CAR-T program, 50% of staffnews2025-01-30T16:04:27+00:00January 30th, 2025|Endpoints News|
Judge allows Aurion Biotech’s path to IPO despite Alcon objectionsnews2025-01-29T09:35:39+00:00January 29th, 2025|Endpoints News|
Cell therapy biotech Affini-T Therapeutics appears to cut staffnews2025-01-27T20:53:02+00:00January 27th, 2025|Endpoints News|
Aurion Biotech files for IPO amid legal battle with Alconnews2025-01-27T14:48:51+00:00January 27th, 2025|Endpoints News|
Swarm Oncology launches with T cell therapy technology to treat solid tumorsnews2025-01-27T00:00:05+00:00January 27th, 2025|Endpoints News|
Chinese startup begins first clinical trial using CRISPR to edit cells directly in the bone marrownews2025-01-22T20:02:34+00:00January 22nd, 2025|Endpoints News|
FDA rejects Atara’s cell therapy for rare transplant complication, stock cratersnews2025-01-16T14:27:53+00:00January 16th, 2025|Endpoints News|
